Volume 28, Number 7—July 2022
Research Letter
Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan
Figure

Figure. Clinical course after immune checkpoint inhibitors treatment initiation for type 1 diabetes mellitus associated with nivolumab after second SARS-CoV-2 vaccination, Japan. Numbers above bars are percentage glycated hemoglobin values.